The urinary tract infection market is expanding as recurrent infections, antimicrobial resistance, ageing populations, and wider access to diagnostic services increase demand for effective treatment and testing. The market was valued at USD 10.8 billion in 2024 and is expected to reach USD 13.43 billion by 2035, growing at a CAGR of 2.0%.

Urinary tract infections can affect the urethra, bladder, and kidneys. Cystitis is the largest application segment, accounting for approximately 54% of market demand because it is one of the most commonly diagnosed forms of urinary infection. Pyelonephritis is a fast-growing segment because kidney-related infections can require more intensive evaluation and management.

Antimicrobial resistance is an important market driver. The increased frequency of resistant bacterial infections is encouraging healthcare providers to improve diagnostic precision before selecting treatment pathways. Rapid diagnostic tools, urine culture testing, antimicrobial susceptibility testing, and molecular assays may help clinicians identify pathogens and support more appropriate treatment decisions.

Quinolones are the largest drug-class segment, holding around 41% of the market. Beta-lactam and cephalosporin therapies are growing quickly as providers seek alternatives that can address changing resistance patterns. Treatment selection should always follow local guidelines, patient-specific factors, and professional clinical assessment.

Hospitals are the largest end-user segment because they manage complex, recurrent, and severe infections. Clinics are growing quickly as outpatient care and telehealth make early consultation more accessible. Home-based care may become more relevant for uncomplicated cases through remote follow-up and digital prescription support.

Read more: Urinary Tract Infection Market 1015

FAQs

Q1. Which UTI application segment leads the market?
Cystitis leads because of its high prevalence and broad outpatient treatment demand.

Q2. Why is antimicrobial resistance important in UTIs?
It increases the need for accurate diagnostics and targeted treatment decisions.

Tags: urinary tract infection market, cystitis, antimicrobial resistance, UTI diagnostics, infection management